Cargando…
Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics
BACKGROUND: Healthcare decisions made on the basis of insufficient evidence may potentially have ineffective or even harmful consequences. The proportion of older ages (over 65 years) in randomized controlled trials (RCTs) for severe asthma is not enough to establish whether anti-IL-5/IL-5R therapie...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
World Allergy Organization
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6931205/ https://www.ncbi.nlm.nih.gov/pubmed/31890084 http://dx.doi.org/10.1016/j.waojou.2019.100081 |